Heart Failure (HF) Clinical Trial
Official title:
An Open-Label, Multicenter, Phase 4 Study to Demonstrate the Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.
This aim of the study is to investigate the prognostic usefulness of AdreView™ imaging to identify those subjects with New York Heart Association (NYHA) Class II or III HF who will die during 60 months of follow-up from the date of administration of AdreView™ in prior studies MBG311, MBG312, or MBG312C (hereafter included in MBG312).
n/a
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03456856 -
A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
|
Phase 4 | |
| Completed |
NCT03901729 -
A Trial to Study BAY1753011 in Patients With Congestive Heart Failure
|
Phase 2 | |
| Completed |
NCT02301689 -
SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register
|
||
| Completed |
NCT04915118 -
A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF
|
||
| Completed |
NCT02200822 -
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients
|
Phase 4 | |
| Recruiting |
NCT04149743 -
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
|
N/A | |
| Recruiting |
NCT05652218 -
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
|
N/A | |
| Completed |
NCT01936649 -
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
|
Phase 4 |